A connection between lung health and kidney function in adults with cystic fibrosis (CF), identifying early urinary markers ...
The Baylor Medicine Maconda Brown O'Connor, Ph.D., Adult Cystic Fibrosis Center provides the highest quality care in a compassionate, patient-centered setting. Our center, which is accredited by the ...
In 1997, the National Institutes of Health convened a Consensus Development Conference on Cystic Fibrosis (CF ... CF carrier screening and to develop “Clinical and Laboratory Provider Guidelines ...
LCI proves valuable in monitoring ETI therapy effectiveness for cystic fibrosis patients with minimal FEV1 changes, detecting ...
Alice Cystic fibrosis symptoms usually start in early childhood ... NICE said an independent committee was looking into the clinical and cost effectiveness of using Kaftrio. It said the review ...
Cystic fibrosis (CF) is an autosomal recessive disorder caused by mutations in the CF transmembrane regulator (CFTR) gene, leading to progressive lung disease and systemic complications. Lung disease ...
The successful use of inhaled morphine to relieve dyspnea in a patient with end-stage cystic fibrosis (CF ... due to the lack of large-scale clinical trials.
The medicine, called trikafta, can treat cystic fibrosis patients who have at least one F508del mutation in the transmembrane conductance regulator gene or a mutation that is responsive to trikafta ...
Alyftrek is approved as a new treatment for cystic fibrosis, while the FDA expanded the label for Trikafta to include additional genetic mutations.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback